Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
124 studies found for:    aspirin | United States, New York | Studies with Male Participants
Show Display Options
Rank Status Study
21 Recruiting Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
Conditions: Cardiovascular Disease;   High Blood Pressure
Interventions: Behavioral: Million Hearts ABCS 6 Months;   Behavioral: Million Hearts ABCS 9 Months;   Behavioral: Million Hearts ABCS 12 Months;   Behavioral: Million Hearts ABCS 15 Months;   Behavioral: Standard Care Regimen 9 Months;   Behavioral: Standard Care Regimen 12 Months;   Behavioral: Standard Care Regimen 15 Months;   Behavioral: Standard Care Regimen 18 Months;   Behavioral: Standard Care Regimen 21 Months;   Behavioral: Standard Care Regimen 24 Months;   Behavioral: Standard Care Regimen 27 Months;   Behavioral: Follow Up Post Intervention 21 Months;   Behavioral: Follow Up Post Intervention 24 Months;   Behavioral: Follow Up Post Intervention 27 Months;   Behavioral: Follow Up Post Intervention 30 Months;   Behavioral: Follow Up Post Intervention 33 Months
22 Completed Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease (AERD)
Interventions: Drug: Ifetroban, Oral Capsule;   Drug: Placebo, Oral Capsule
23 Completed Reversing Ticagrelor's Effects With Fresh Platelets
Condition: Coronary Artery Disease
Interventions: Drug: Loading dose;   Drug: Maintenance dose
24 Terminated Improving Medication Adherence in Post-ACS Patients
Conditions: Medication Adherence;   Acute Coronary Syndrome
Intervention: Behavioral: PST therapy
25 Terminated A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Simvastatin;   Drug: Aspirin;   Drug: Placebo
26 Completed Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition
Conditions: Percutaneous Coronary Intervention;   Dual Antiplatelet Therapy;   Aspirin;   Clopidogrel
Intervention:
27 Active, not recruiting Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Condition: Cancer Patients First-ever Acute Ischemic Stroke
Interventions: Drug: Enoxaparin;   Drug: Aspirin
28 Completed
Has Results
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Conditions: Heart Disease;   Stroke;   Ischemic Heart Disease;   Myocardial Infarction
Interventions: Drug: aspirin;   Drug: Warfarin
29 Recruiting Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
30 Completed
Has Results
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
Condition: Acute Migraine
Interventions: Drug: Acetaminophen 250 mg and Aspirin 250 mg;   Drug: Placebo
31 Completed Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Condition: Colorectal Cancer
Interventions: Drug: aspirin;   Other: placebo
32 Completed Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument
Condition: Bleeding Disorder
Intervention:
33 Recruiting A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Condition: Acute Coronary Syndromes
Interventions: Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
34 Active, not recruiting A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
Condition: Moderate Risk of CVD
Interventions: Drug: Aspirin (Acetylsalicylic acid, BAYE4465);   Drug: Placebo
35 Completed [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Conditions: Acute Ischaemic Stroke;   Transient Ischaemic Attack.
Interventions: Drug: ticagrelor;   Drug: Acetylsalicylic acid (ASA)
36 Completed Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes
Condition: Cardiovascular Diseases
Interventions: Other: Usual Care;   Behavioral: Concurrent Peer Review visit
37 Enrolling by invitation ASPREE Cancer Endpoints Study
Condition: Cancer
Interventions: Drug: Aspirin;   Drug: Placebo
38 Completed Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Condition: Osteoarthritis
Interventions: Behavioral: Coping skills training (CST) for chronic pain;   Other: Usual care
39 Unknown  Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
Conditions: Coronary Artery Disease;   Platelet Aggregation Inhibitors;   PCI- Percutaneous Coronary Intervention
Interventions: Drug: Loading Dose Arm;   Drug: Maintenance Dose Arm
40 Completed
Has Results
Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
Condition: Pain, Migraine
Interventions: Drug: Aspirin, acetaminophen and caffeine;   Drug: Sumatriptan;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.